MVIS.NASDAQMicrovision, INC

Form 4: MicroVision Director Simon Biddiscombe Reports RSU Vesting and New Equity Grant

Sentiment:

Insider Transaction Report


MicroVision, Inc. Director Simon Biddiscombe reported the vesting of 20,112 restricted stock units into common stock and the grant of 87,642 new restricted stock units as part of his compensation.

Summary

  • Simon Biddiscombe, a Director at MicroVision, Inc. (MVIS), reported changes in his beneficial ownership of company securities.
  • On June 5, 2025, 20,112 restricted stock units (RSUs) vested and converted into an equal number of common stock shares without payment.
  • Following this vesting, Mr. Biddiscombe's direct beneficial ownership of common stock increased to 225,278 shares.
  • On June 6, 2025, Mr. Biddiscombe was granted 87,642 new restricted stock units.
  • Each new RSU represents a contingent right to receive one share of MicroVision common stock.
  • The newly granted RSUs are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided he continues to serve as a director.

Sentiment

Score: 5

Explanation: The document reports routine insider transactions related to director compensation (RSU vesting and new grant). This is a neutral event, reflecting standard corporate governance and compensation practices, with no inherently positive or negative implications for the company's operational or financial performance.

Positives

  • The vesting of RSUs and grant of new RSUs align the director's interests with those of shareholders, as his compensation is tied to the company's equity performance.
  • The continued grant of equity compensation to a director indicates ongoing commitment and retention of key management personnel.

Future Outlook

The newly granted 87,642 restricted stock units are scheduled to vest in four equal quarterly installments, with full vesting occurring on the earlier of the first anniversary of the grant date (June 6, 2026) or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on the director's continued service.

Management Comments

  • Vested restricted stock units (RSUs) were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
  • At vesting, RSUs convert into shares of common stock on a unit-for-share basis, without payment.
  • Each RSU represents a contingent right to receive one share of MicroVision common stock.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction related to director compensation and does not provide specific insights into broader industry trends or competitive positioning.

Stakeholder Impact

  • Shareholders: The vesting and grant of RSUs result in a slight increase in the number of outstanding shares over time, leading to minor dilution. However, it also aligns the director's interests with shareholder value creation.

Next Steps

  • Future vesting of the 87,642 newly granted restricted stock units in four equal quarterly installments, contingent on continued service as a director.

Key Dates

DateDescription
06/05/2024Grant date for RSUs that vested on 06/05/2025.
06/05/2025Vesting date for 20,112 restricted stock units (RSUs) into common stock; also the expiration date for these RSUs.
06/06/2025Grant date for 87,642 new restricted stock units.
2025 Annual Meeting of StockholdersEarlier of the first anniversary of the grant date or the day prior to this meeting, serving as a vesting condition for RSUs granted on 06/05/2024.
2026 Annual Meeting of StockholdersEarlier of the first anniversary of the grant date or the day prior to this meeting, serving as a vesting condition for RSUs granted on 06/06/2025.

Keywords

MicroVision, MVIS, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Stock Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.